New paper below, [1].
Nalakrats & I believe there is a role for a 5-alpha reductase inhibitor in advanced PCa. Some disagree. I would be remiss if I didn't point out that long-term use (as with all PCa drugs) has a downside:
"This treatment may result in development of non-alcoholic fatty liver diseases (NAFLD), insulin resistance (IR), type 2 diabetes (T2DM), dry eye disease, potential kidney dysfunction, among other metabolic dysfunctions."
When my prostatectomy failed 16 years ago, I wasn't concerned that salvage radiation increased the risk of other cancers. Those risks were not apparent for 5 years. I was starting to think short term.
For those taking the long view, this paper may be of interest.
Incidentally, Avodart has a long half-life. Taking a vacation from the drug isn't so easy.
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/322...
Review World J Mens Health
2020 Mar 20[Online ahead of print]
Health Risks Associated With Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
Abdulmaged M Traish 1
Affiliations collapse
Affiliation
1 Department of Urology, Boston University School of Medicine, Boston, MA, USA. atraish@bu.edu.
PMID: 32202088 DOI: 10.5534/wjmh.200012
Abstract
5α-dihydrotestosterone (5α-DHT) is the most potent natural androgen. 5α-DHT elicits a multitude of physiological actions, in a host of tissues, including prostate, seminal vesicles, hair follicles, skin, kidney, and lacrimal and meibomian glands. However, the physiological role of 5α-DHT in human physiology, remains questionable and, at best, poorly appreciated. Recent emerging literature supports a role for 5α-DHT in the physiological function of liver, pancreatic b-cell function and survival, ocular function and prevention of dry eye disease and kidney physiological function. Thus, inhibition of 5α-reductases with finasteride or dutasteride to reduce 5α-DHT biosynthesis in the course of treatment of benign prostatic hyperplasia (BPH) or male pattern hair loss, known as androgenetic alopecia (AGA) my induces a novel form of tissue specific androgen deficiency and contributes to a host of pathophysiological conditions, that are yet to be fully recognized. Here, we advance the concept that blockade of 5α-reductases by finasteride or dutasteride in a mechanism-based, irreversible, inhabitation of 5α-DHT biosynthesis results in a novel state of androgen deficiency, independent of circulating testosterone levels. Finasteride and dutasteride are frequently prescribed for long-term treatment of lower urinary tract symptoms in men with BPH and in men with AGA. This treatment may result in development of non-alcoholic fatty liver diseases (NAFLD), insulin resistance (IR), type 2 diabetes (T2DM), dry eye disease, potential kidney dysfunction, among other metabolic dysfunctions. We suggest that long-term use of finasteride and dutasteride may be associated with health risks including NAFLD, IR, T2DM, dry eye disease and potential kidney disease.
Keywords: 5-alpha reductase inhibitors; Diabetes mellitus; Dry eye syndromes; Hypogonadism; Kidney diseases; Non-alcoholic fatty liver disease.
Copyright © 2020 Korean Society for Sexual Medicine and Andrology.